Tenders Are Invited For Medical Practice And Related Services – 21-Gene Genomic Examination. (Oncotype Dx) Procedure

Medical Practice And Related Services – 21-Gene Genomic Examination. (Oncotype Dx) Procedure. Performing 21-Gene Genomic Tests (Oncotype Dx) For Semmelweis University: A Prognostic And Predictive Test Examining 21 Genes, With A 1A Level Of Evidence, Which Enables Chemotherapy Decisions. Patient Group: Her2 Positive, Her2 Negative, Hormone Receptor Positive Early (No, N1) Breast Cancer. The Task Of The Successful Tenderer Is To: - Transport The Samples Produced During The Tests To The Test Site; - Carrying Out The Tests; - The Evaluation Of The Results In A Mathematical Form; - Issue Of Recurrence Score; - Validation Of Estrogen Receptor, Progesterone Receptor And Her2 Receptor Values; - Consultation With The Attending Physician About The Completed Findings; Planned Quantity For 36 Months: 200 Tests. The Framework Contract Will Remain In Effect For 36 Months After Its Signature, Or Until The Framework Amount Is Exhausted - Which Is Huf 111,800,000 Net. The Tenderer Undertakes To Draw 70% Of The Framework Quantity. The Exact Technical Data And Professional Expectations Are Contained In The Technical Description That Is Part Of The Public Procurement Document.